Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data

Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data

Abstract Background To evaluate incidence of opportunistic infections (OIs) in patients with rheumatoid arthritis (RA) treated with abatacept in clinical trials. Methods This pooled analysis of 16 randomized, double-blind/open-label trials, with ≥ 1 abatacept (intravenous or subcutaneous) arm, and w...

Full description

Bibliographic Details
Main Authors: Teresa A. Simon, Lixian Dong, Kevin L. Winthrop
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Arthritis Research & Therapy
Subjects:
Abatacept
Infection
Opportunistic infections
Herpes
Serious infection
Shingles
Online Access:https://doi.org/10.1186/s13075-020-02399-2

Similar Items

Similar Items